Tumor lysis syndrome natural history, complications and prognosis
Tumor lysis syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tumor lysis syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Tumor lysis syndrome natural history, complications and prognosis |
FDA on Tumor lysis syndrome natural history, complications and prognosis |
CDC on Tumor lysis syndrome natural history, complications and prognosis |
Tumor lysis syndrome natural history, complications and prognosis in the news |
Blogs on Tumor lysis syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
If left untreated, patients with tumor lysis syndrome may progress to develop nausea, vomiting, diarrhea, anorexia, hematuria, palpitations, and muscle cramps. Common complications of tumor lysis syndrome include hyperkalemia, hypocalcemia, and hyperphosphatemia. Prognosis is generally good, if not associated with acute renal failure.[1]
Natural History
If left untreated, patients with tumor lysis syndrome may progress to develop nausea, vomiting, diarrhea, anorexia, hematuria, heart palpitations, and muscle cramps. Eventually, tumor lysis syndrome may lead to death.[1] [2]
Complications
- Life-threatening conditions may result in death or permanent disability within 24 hours if left untreated.[1]
*Acute kidney injury
Prognosis
The prognosis of tumor lysis syndrome is good with treatment and if not associated with renal failure. Without treatment, tumor lysis syndrome will result in cardiac arrhythmia and electrolytes disturbance.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Coiffier B, Altman A, Pui CH, Younes A, Cairo MS (2008). "Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review". J Clin Oncol. 26 (16): 2767–78. doi:10.1200/JCO.2007.15.0177. PMID 18509186.
- ↑ Cairo MS, Bishop M (2004). "Tumour lysis syndrome: new therapeutic strategies and classification". Br J Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.